Celebrating 20 Years of Oxaloacetate Research at A4M 2025

The Terra Biological team is eager to reconnect with the longevity, integrative medicine, and functional health communities at the A4M Conference 2025 in Las Vegas. If you will be in attendance, please visit our team at booth #1095. 

In 2025, we celebrate 20 years of pioneering research with oxaloacetate, a journey that has grown from early biochemical insights all the way to clinical applications like Oxaloacetate CFS that impact the lives of thousands across the globe. Over the past two decades, Terra Biological has partnered with leading researchers, physicians, and academic centers worldwide to deepen scientific understanding and bring forward innovations designed to support real people facing real challenges.

This milestone isn’t just an anniversary—it’s a testament to what consistently high scientific standards and collaborative research efforts can achieve.

This progress has been possible with the dedicated work of a community of scientists, clinicians, patients and research institutions who have advanced oxaloacetate research. We’re proud to recognize the partners whose work helped build the evidence base behind oxaloacetate and Oxaloacetate CFS, including:

• University of California, San Diego (UCSD)

• University of California, Los Angeles (UCLA)

• Stanford University

• University of Melbourne, Australia
  
  

• University of Kansas

• Boston College

• Louisiana State University

• Mount Sinai Health System
  
  

• University of Michigan

• Bateman Horne Center

While the clinical research of oxaloacetate for amelioration of fatigue is just beginning, Oxaloacetate CFS is already one of the most thoroughly researched and tested therapies for ME/CFS today. Most importantly, Oxaloacetate CFS helps thousands of ME/CFS patients in more than 35 countries.